PubMed · 2014 · 10 citations · 3 references
PharmacyPharmacotherapyPsychiatryCardiovascular PharmacotherapyPsychiatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapySchizophrenia PharmacotherapySchizophrenia Spectrum DisordersTreatment-resistant Psychiatric DisordersAcute Adverse EventsAntipsychotic Medication ManagementAntipsychotic Treatment InitiationAntipsychotic-associated CardiotoxicityClozapine PharmacologySchizophrenia ComorbiditySerious Adverse Events
OBJECTIVE: Clozapine is an atypical antpsychotic medication with established efficacy in patients diagnosed of resistant schizophrenia. However, clozapine has multiple side effects. Cardiac complications such as myocarditis and cardiomyopathy have always been related with treatment with clozapine. METHODS: A 42 year old Caucasian male, with history of schizophrenia developed a acute myocarditis after commencement of clozapine. RESULTS: The patient recovered with intensive medical support. The symptoms occurred approximately 20 days after starting clozapine. CONCLUSIONS: Myocarditis is an ingreasingly recognized complication associated with clozapine. Use of clozapine must be based on a balance of its risks and benefits on an individual basis which for the most part defines its use in treatment refractory schizophrenia. Appropriate monitoring of adverse events is an essential part of the clinical usage of clozapine and should be charted for at least two years.
3
Myocarditis and cardiomyopathy associated with clozapine
Jens Kilian, K. M. Kerr, Christopher Lawrence et al. · The Lancet · 1999 · 546 citations
Myocarditis Related to Clozapine Treatment
Staffan Hägg, Olav Spigset, Andrew Bate BAHons et al. · Journal of Clinical Psychopharmacology · 2001 · 142 citations